Breast cancer
Theragnostic testing – choosing the right therapy in mTNBCPetra (64 years old)
Petra, 64 years old, intended to train for a 10 km walk after her treatment for early stage TNBC. Unfortunately, her physical condition never allowed her to properly start training, and now she is diagnosed with mTNBC.
Assessment summary
- Postmenopausal
- Cancer family history: mother had ovarian cancer at the age of 70 years
- Genetic panel analysis: no pathogenic variants in BRCA1/2 and PALB2
- Medical history
- Hashimoto-thyroiditis (well-controlled hypothyroidism, normal thyroid function parameters under l-thyroxin 50 µg/d), mild arterial hypertonia
- Diagnosis early stage TNBC (cT2N1M0, right side)
- Neoadjuvant anthracycline-taxane chemotherapy
- Mastectomy, sentinel lymphadenectomy and targeted axillary dissection (pCR: ypT0 ypN0)
- Today, 16 months later, staging including CT scan of chest/abdomen and bone scan
- 2 suspicious liver lesions and multiple suspicious pleural lesions
- Biopsy (liver lesion)
- Breast cancer, ER 0%, PgR 0%, HER2 IHC 1+, G2
- PD-L1 status: CPS 6, IC score 5%
- ECOG PS: 0